Veterinary Vaccine
The main goal to produce the veterinary vaccine is to improve the health of the animals also its welfare. By increasing the production of veterinary vaccines, the animal to human transmitted diseases from both domestic and wildlife can be prevented. Commonly the dog vaccines ( Vaccines for canine parvovirus, canine hepatitis and rabies are considered core vaccines. Non-core vaccines are given depending on the dog's exposure risk. These include vaccines against Bordetella bronchiseptica, Borrelia burgdorferi, and Leptospira bacteria is as popular as the veterinary vaccine.The infectious diseases that get transmitted to humans from animals can be prevented
Related Conference of Veterinary Vaccine
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Veterinary Vaccine Conference Speakers
Recommended Sessions
- Vaccine Safety and Efficacy
- Clinical Immunology and Allergy
- Human Vaccines-infectious & non- infectious
- Immunogenicity and Immune Tolerance
- Immunoinformatics
- Immunological Disorders
- Immunology and Immune System
- Immunotoxicology
- Infection and Immunity
- OncoImmunology
- Paediatric Immunology
- Parasite Immunology
- Pathology and Immunology
- Vaccine & Immunization
- Vaccines Against Drugs
- Veterinary Vaccine
- Viral Immunology: Emerging and Re-emerging Diseases
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
